NT5DC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.721800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.201800E-01
Normal-vs-Stage2
4.731000E-01
Normal-vs-Stage3
3.264200E-01
Normal-vs-Stage4
8.808600E-01
Stage1-vs-Stage2
8.012800E-01
Stage1-vs-Stage3
7.353600E-01
Stage1-vs-Stage4
3.005000E-01
Stage2-vs-Stage3
5.253800E-01
Stage2-vs-Stage4
3.242400E-01
Stage3-vs-Stage4
2.266600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.351400E-01
Normal-vs-AfricanAmerican
8.965000E-01
Normal-vs-Asian
6.378400E-01
Caucasian-vs-AfricanAmerican
1.930390E-01
Caucasian-vs-Asian
9.374800E-01
AfricanAmerican-vs-Asian
4.560800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.252200E-01
Normal-vs-Female
5.380800E-01
Male-vs-Female
6.449200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.775200E-01
Normal-vs-Age(41-60Yrs)
7.839800E-01
Normal-vs-Age(61-80Yrs)
3.164400E-01
Normal-vs-Age(81-100Yrs)
5.212200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.484000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.535400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.930200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.282300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.954600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.242000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.899600E-01
Normal-vs-Daily Drinker
2.429600E-01
Normal-vs-Weekly Drinker
3.023600E-01
Normal-vs-Occasional Drinker
6.608600E-01
Normal-vs-Social Drinker
6.014600E-01
Non Drinker-vs-Daily Drinker
2.480200E-01
Non Drinker-vs-Weekly Drinker
3.776600E-01
Non Drinker-vs-Occasional Drinker
7.955400E-01
Non Drinker-vs-Social Drinker
8.673600E-01
Daily Drinker-vs-Weekly Drinker
9.208400E-01
Daily Drinker-vs-Occasional Drinker
1.803440E-01
Daily Drinker-vs-Social Drinker
2.159200E-01
Weekly Drinker-vs-Occasional Drinker
2.831200E-01
Weekly Drinker-vs-Social Drinker
3.166800E-01
Occasional Drinker-vs-Social Drinker
9.354000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.341830E-01
Normal-vs-Grade 2
4.473700E-02
Normal-vs-Grade 3
4.170300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.032800E-01
Grade 1-vs-Grade 3
2.507000E-01
Grade 1-vs-Grade 4
1.341830E-01
Grade 2-vs-Grade 3
4.083600E-01
Grade 2-vs-Grade 4
4.473700E-02
Grade 3-vs-Grade 4
4.170300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.606200E-01
Normal-vs-NonDiabetic
4.030200E-01
Diabetic-vs-NonDiabetic
7.765000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.217400E-01
Normal-vs-NoPancreatitis
4.288800E-01
Pancreatitis-vs-NoPancreatitis
7.235000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.536800E-01
Normal-vs-N1
4.379600E-01
N0-vs-N1
6.206600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.847200E-01
Normal-vs-TP53-NonMutant
9.609400E-01
TP53-Mutant-vs-TP53-NonMutant
8.178200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
